What is Microbiological Testing & Consulting?
Based in Chicago, Illinois, Microbiological Testing & Consulting (MTC) operates as an FDA-registered laboratory dedicated to the rigorous assessment of microbial safety. With a legacy spanning over two decades, the firm provides critical services including preservation, stability, and compatibility testing. MTC is particularly recognized for its expertise in USP 60 testing, a vital protocol for detecting Burkholderia cepacia complex in consumer and medical products. By bridging the gap between complex regulatory requirements and commercial product development, MTC serves as a cornerstone for manufacturers striving to maintain the highest standards of safety and compliance in an increasingly scrutinized global market.
How much funding has Microbiological Testing & Consulting raised?
Microbiological Testing & Consulting has raised a total of $45K across 1 funding round:
Debt
$45K
Debt (2021): $45K with participation from PPP
Key Investors in Microbiological Testing & Consulting
PPP
Public-Private Partnership
What's next for Microbiological Testing & Consulting?
With the infusion of this recent capital, MTC is expected to scale its laboratory infrastructure to meet the rising demand for advanced microbial diagnostics. The strategic roadmap likely involves expanding its technical team and investing in high-throughput testing technologies to reduce turnaround times for clients. As regulatory landscapes continue to evolve, MTC is well-positioned to deepen its consulting arm, providing manufacturers with the technical foresight required to navigate complex safety mandates. This growth phase marks a transition from a specialized service provider to a broader platform for quality assurance, ensuring that MTC remains at the forefront of the microbiological testing industry.
See full Microbiological Testing & Consulting company page
